Metabolic syndrome: New targets for an old problem

Expert Opinion on Therapeutic Targets

Volumn 16, Issue 2, 2012, Pages 147-150

  Dichi, Isaias ^a   Simão, Andrea Name Colado ^a  

^a UNIVERSITY OF LONDRINA   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDOTHELIAL NITRIC OXIDE SYNTHASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; METFORMIN; NITRIC OXIDE; OMEGA 3 FATTY ACID; SIBUTRAMINE; TETRAHYDROLIPSTATIN; TROGLITAZONE; TUMOR NECROSIS FACTOR ALPHA; URIC ACID;

ENDOTHELIAL DYSFUNCTION; HUMAN; INFLAMMATION; INSULIN RESISTANCE; METABOLIC SYNDROME X; NONHUMAN; OXIDATIVE STRESS; REVIEW;

ANIMALS; ENDOTHELIAL CELLS; HUMANS; INFLAMMATION; METABOLIC SYNDROME X; OXIDATIVE STRESS; URIC ACID;

EID: 84857429959     PISSN: 14728222     EISSN: 17447631     Source Type: Journal    
DOI: 10.1517/14728222.2012.648924     Document Type: Review

References (21)

1. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988;37:1595-607
2. Simao ANC, Lozovoy MAB, Simao TNC, et al. Immunological and biochemical biomarkers in patients with metabolic syndrome and involvement of oxidative and nitroactive stress. Braz J Med Biol Res 2011;44:707-12
3. Lozovoy MAB, Simao ANC, da Silva E, et al. Inflammatory biomarkers and oxidative stress measurements in patients with systemic lupus erythematosus with or without metabolic syndrome. Lupus 2011;20:1356-64
4. Albert MA, Danielson E, Rifai N, Ridker PM; PRINCE Investigators. Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study. JAMA 2001;286:64-70
5. Ouchi N, Kihara S, Arita Y, et al. Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway. Circulation 2000;102:1296-301
6. Simao ANC, Lozovoy MAB, Simao TNC, et al. Adiponectinemia is associated with uricemia but not with proinflammatory status in women with metabolic syndrome. J Nutr Metab 2011;2012(2012):7
7. Santaniemi M, Kesaniemi YA, Ukkola O. Low plasma adiponectin concentration is an indicator of the metabolic syndrome. Eur J Endocrinol 2006;155:745-50
8. Zhu W, Cheng KKY, Vanhoutte PM, et al. Vascular effects of adiponectin: molecular mechanisms and potential therapeutic intervention. Clin Sci 2008;114:361-74
9. Simao ANC, Lozovoy MAB, Bahls LD, et al. Blood pressure decrease with ingestion of a soy product (kinako) or fish oil in women with metabolic syndrome: role of adiponectin and nitric oxide. Br J Nutr; In press
10. Goldstein BJ, Scalia R. Adiponectin: a novel adipokine linking adypocytes and vascular function. J Clin Endocrinol Metab 2004;89:2563-8
11. Ohashi K, Kihara S, Ouchi N, et al. Adiponectin replenishment ameliorates obesity-related hypertension. Hypertension 2006;47:1108-16
12. Ziemke F, Mantzoros CS. Adiponectin in insulin resistance: lessons from translational research. Am J Clin Nutr 2010;91(Suppl):258S-61S
13. Ouchi N, Ohishi M, Kihara S, et al. Association of hypoadiponectinemia with impaired vasoreactivity. Hypertension 2003;42:231-4
14. Hermann M, Flammer A, Luscher TF. Nitric oxide in hypertension. J Clin Hypertens 2006;8(12 Suppl):17-29
15. Skalicky J, Muzakova V, Kandar R, et al. Evaluation of oxidative stress and inflammation in obese adults with metabolic syndrome. Clin Chem Lab Med 2008;46:499-505
16. Yamaguchi Y, Yoshikawa N, Kagota S. Elevated circulating levels of markers of oxidative-nitrative stress and inflammation in a genetic rat model of metabolic syndrome. Nitric Oxide 2006;15:380-6
17. Nakagawa T, Hu H, Zharikov S, et al. A causal role for uric acid in fructose-induced metabolic syndrome. Am J Physiol Renal Physiol 2006;290:F625-31
18. Niskanen LK, Laaksonen DE, Nyyssonen K, et al. Uric acid level as a risk for cardiovascular and all-mortality in middle-age men: a prospective cohort study. Arch Intern Med 2004;164:1546-51
19. Simao ANC, Dichi JB, Barbosa DS, et al. Influence of uric acid and gamma-glutamyltransferase on total antioxidant capacity and oxidative stress in patients with metabolic syndrome. Nutrition 2008;24:675-81
20. Simao ANC, Dichi I. Role of uric acid in metabolic syndrome. In: Castillo SE, Maldonado EW, editors. Uric Acid: Biology, Functions and Diseases. Nova Science Publishers; New York: 2012; In press
21. Munzel T. Is oxidative stress a therapeutic target in cardiovascular disease? Eur Heart J 2010;31:2741-8 167-178